ALUNBRIG® is a prescription medicine used to treat people with non-small cell lung cancer (NSCLC):

  • that has a certain type of abnormal anaplastic lymphoma kinase (ALK) gene, and
  • that has spread to other parts of your body, and
  • who have taken the medicine crizotinib, but their NSCLC worsened or they cannot tolerate taking crizotinib.

It is not known if ALUNBRIG is safe and effective in children.

Patient Support

ALUNBRIG 1Point is here to work with you throughout the course of your therapy.

  • Access: A Patient Access Specialist can work with you and your healthcare provider to conduct a benefits investigation and provide you both with details on your drug coverage and options
  • Afford: Regardless of your insurance status, ALUNBRIG 1Point can help identify an array of financial assistance programs for which you may be eligible
  • Assist: ALUNBRIG 1Point is committed to supporting you throughout your treatment by offering a wide range of services to get you the information you need, and assist with day-to-day concerns associated with your treatment
Find Out More

Stay Connected

Stay in the loop about ALUNBRIG. Join now to receive useful information and updates about ALUNBRIG.

Required fields*

Please enter your first name.
Please enter your last name.
Please enter your email.
Please select the option that best describes you.
Please select your state.
Submit

You Have Successfully Registered

Thank you for registering. You will hear from us when we have updates.

You are now leaving ALUNBRIG.com, the official site for ALUNBRIG® (brigatinib).

This link will take you to the corporate Takeda Oncology website.

Continue Cancel

You are now leaving ALUNBRIG.com, the official site for ALUNBRIG® (brigatinib).

This link will take you to the ALUNBRIG 1Point website.

Continue Cancel

You are now leaving ALUNBRIG.com, the official site for ALUNBRIG® (brigatinib).

This link will take you to the FDA website.

Continue Cancel

The site you are about to enter is intended for US healthcare professionals only.

Please confirm that you are a US healthcare professional.

Yes, I confirm that I am a US healthcare professional Cancel